Recall Record

Mumbai, India

JB Chemicals and Pharmaceuticals Ltd recalls

3 recalls recorded since 2018, most recently on 24 June 2026. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)3
Terminated or completed0
Class I (FDA)1

Ongoing Class I Drugs

Recall started
24 June 2026
Reason
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0732-2026

Ongoing Class II Drugs

Recall started
23 April 2026
Reason
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0520-2026

Ongoing Class III Drugs

Recall started
12 September 2025
Reason
Tablet/Capsules Imprinted with Wrong ID
Distribution
U.S. Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0032-2026, D-0033-2026

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.